Pub Date : 1976-01-01DOI: 10.1016/S0362-5486(76)80026-X
Inder J. Chopra, David H. Solomon
{"title":"Thyroid function tests and their alterations by drugs","authors":"Inder J. Chopra, David H. Solomon","doi":"10.1016/S0362-5486(76)80026-X","DOIUrl":"10.1016/S0362-5486(76)80026-X","url":null,"abstract":"","PeriodicalId":101017,"journal":{"name":"Pharmacology & Therapeutics. Part C: Clinical Pharmacology and Therapeutics","volume":"1 3","pages":"Pages 367-399"},"PeriodicalIF":0.0,"publicationDate":"1976-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0362-5486(76)80026-X","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77289912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1976-01-01DOI: 10.1016/S0362-5486(76)80025-8
Clark T. Sawin, Jerome M. Hershman
{"title":"Clinical use of thyrotropin-releasing hormone","authors":"Clark T. Sawin, Jerome M. Hershman","doi":"10.1016/S0362-5486(76)80025-8","DOIUrl":"10.1016/S0362-5486(76)80025-8","url":null,"abstract":"","PeriodicalId":101017,"journal":{"name":"Pharmacology & Therapeutics. Part C: Clinical Pharmacology and Therapeutics","volume":"1 3","pages":"Pages 351-366"},"PeriodicalIF":0.0,"publicationDate":"1976-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0362-5486(76)80025-8","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82215063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1976-01-01DOI: 10.1016/S0362-5486(76)80013-1
R. Volpe
{"title":"Acute and subacute thyroiditis","authors":"R. Volpe","doi":"10.1016/S0362-5486(76)80013-1","DOIUrl":"https://doi.org/10.1016/S0362-5486(76)80013-1","url":null,"abstract":"","PeriodicalId":101017,"journal":{"name":"Pharmacology & Therapeutics. Part C: Clinical Pharmacology and Therapeutics","volume":"116 1","pages":"171-181"},"PeriodicalIF":0.0,"publicationDate":"1976-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75999337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1976-01-01DOI: 10.1016/S0362-5486(76)80010-6
H. Verdain Barnes
The therapy of thyrotoxicosis in children and adolescents requires careful selection of a primary mode of therapy and secondary therapy if the hypermetabolic manifestations compromise the patient's function at home or in school. The three principle modes of primary therapy, thioamide blockade, subtotal thyroidectomy and radioiodine, are critically reviewed as to advantages, disadvantages, and results. Secondary symptomatic therapy is discussed with an emphasis on the usefulness of beta adrenergic blockade. The application of each potential mode of therapy is discussed. The etiology, natural history, and therapy of neonatal thyrotoxicosis is reviewed. The author concludes that for the majority of patients in this age group with toxic diffuse goiter, definitive thioamide therapy carries the least potential for major complications. An effective approach for utilizing methimazole is outlined.
{"title":"Treatment of hyperthyroidism in children and adolescents","authors":"H. Verdain Barnes","doi":"10.1016/S0362-5486(76)80010-6","DOIUrl":"https://doi.org/10.1016/S0362-5486(76)80010-6","url":null,"abstract":"<div><p>The therapy of thyrotoxicosis in children and adolescents requires careful selection of a primary mode of therapy and secondary therapy if the hypermetabolic manifestations compromise the patient's function at home or in school. The three principle modes of primary therapy, thioamide blockade, subtotal thyroidectomy and radioiodine, are critically reviewed as to advantages, disadvantages, and results. Secondary symptomatic therapy is discussed with an emphasis on the usefulness of beta adrenergic blockade. The application of each potential mode of therapy is discussed. The etiology, natural history, and therapy of neonatal thyrotoxicosis is reviewed. The author concludes that for the majority of patients in this age group with toxic diffuse goiter, definitive thioamide therapy carries the least potential for major complications. An effective approach for utilizing methimazole is outlined.</p></div>","PeriodicalId":101017,"journal":{"name":"Pharmacology & Therapeutics. Part C: Clinical Pharmacology and Therapeutics","volume":"1 1","pages":"Pages 129-147"},"PeriodicalIF":0.0,"publicationDate":"1976-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0362-5486(76)80010-6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91684317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1976-01-01DOI: 10.1016/S0362-5486(76)80010-6
H. Barnes
{"title":"Treatment of hyperthyroidism in children and adolescents","authors":"H. Barnes","doi":"10.1016/S0362-5486(76)80010-6","DOIUrl":"https://doi.org/10.1016/S0362-5486(76)80010-6","url":null,"abstract":"","PeriodicalId":101017,"journal":{"name":"Pharmacology & Therapeutics. Part C: Clinical Pharmacology and Therapeutics","volume":"57 1","pages":"129-147"},"PeriodicalIF":0.0,"publicationDate":"1976-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80616444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1976-01-01DOI: 10.1016/S0362-5486(76)80005-2
Shigenobu Nagataki
{"title":"Iodine-induced goiter; effects of high iodine intake on thyroid function","authors":"Shigenobu Nagataki","doi":"10.1016/S0362-5486(76)80005-2","DOIUrl":"10.1016/S0362-5486(76)80005-2","url":null,"abstract":"","PeriodicalId":101017,"journal":{"name":"Pharmacology & Therapeutics. Part C: Clinical Pharmacology and Therapeutics","volume":"1 1","pages":"Pages 45-56"},"PeriodicalIF":0.0,"publicationDate":"1976-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0362-5486(76)80005-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90072470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1976-01-01DOI: 10.1016/S0362-5486(76)80012-X
John T. Nicoloff
{"title":"Myxedema coma","authors":"John T. Nicoloff","doi":"10.1016/S0362-5486(76)80012-X","DOIUrl":"https://doi.org/10.1016/S0362-5486(76)80012-X","url":null,"abstract":"","PeriodicalId":101017,"journal":{"name":"Pharmacology & Therapeutics. Part C: Clinical Pharmacology and Therapeutics","volume":"1 1","pages":"Pages 161-169"},"PeriodicalIF":0.0,"publicationDate":"1976-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0362-5486(76)80012-X","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91684318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1976-01-01DOI: 10.1016/S0362-5486(76)80024-6
Herbert A. Selenkow , Leslie I. Rose
{"title":"Comparative clinical pharmacology of thyroid hormones","authors":"Herbert A. Selenkow , Leslie I. Rose","doi":"10.1016/S0362-5486(76)80024-6","DOIUrl":"10.1016/S0362-5486(76)80024-6","url":null,"abstract":"","PeriodicalId":101017,"journal":{"name":"Pharmacology & Therapeutics. Part C: Clinical Pharmacology and Therapeutics","volume":"1 3","pages":"Pages 331-349"},"PeriodicalIF":0.0,"publicationDate":"1976-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0362-5486(76)80024-6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84668254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1976-01-01DOI: 10.1016/S0362-5486(76)80027-1
David Lewis Geffner, Jerome M. Hershman
The etiology of Graves’ disease remains unknown. The leading current theory considers it to be an hereditary autoimmune disorder of both humoral and cell-mediated immunity with production of abnormal thyroid stimulators. Uncommon causes of hyperthyroidism include autonomous thyroid nodules, administration of iodine to patients with nodular goiter, subacute thyroiditis, trophoblastic tumors producing molar thyrotropin, large differentiated thyroid carcinomas, struma ovarii, pituitary tumors producing thyrotropin, and taking excessive amounts of thyroid medication.
The clinical features of hyperthyroidism are described. Subtotal thyroidectomy is effective treatment, but has the disadvantage of significant complications which include hypothyroidism, rare mortality, hypoparathyroidism, paralysis of vocal cords and altered voice, recurrence of hyperthyroidism, rare thyroid crisis and morbidity from the wound.
{"title":"Hyperthyroidism. Causes, etiology of Graves’ disease, clinical features, general aspects of treatment","authors":"David Lewis Geffner, Jerome M. Hershman","doi":"10.1016/S0362-5486(76)80027-1","DOIUrl":"10.1016/S0362-5486(76)80027-1","url":null,"abstract":"<div><p>The etiology of Graves’ disease remains unknown. The leading current theory considers it to be an hereditary autoimmune disorder of both humoral and cell-mediated immunity with production of abnormal thyroid stimulators. Uncommon causes of hyperthyroidism include autonomous thyroid nodules, administration of iodine to patients with nodular goiter, subacute thyroiditis, trophoblastic tumors producing molar thyrotropin, large differentiated thyroid carcinomas, struma ovarii, pituitary tumors producing thyrotropin, and taking excessive amounts of thyroid medication.</p><p>The clinical features of hyperthyroidism are described. Subtotal thyroidectomy is effective treatment, but has the disadvantage of significant complications which include hypothyroidism, rare mortality, hypoparathyroidism, paralysis of vocal cords and altered voice, recurrence of hyperthyroidism, rare thyroid crisis and morbidity from the wound.</p></div>","PeriodicalId":101017,"journal":{"name":"Pharmacology & Therapeutics. Part C: Clinical Pharmacology and Therapeutics","volume":"1 3","pages":"Pages 401-422"},"PeriodicalIF":0.0,"publicationDate":"1976-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0362-5486(76)80027-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79990283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1976-01-01DOI: 10.1016/S0362-5486(76)80008-8
G. M. Wilson
{"title":"The treatment of thyrotoxicosis by radioiodine","authors":"G. M. Wilson","doi":"10.1016/S0362-5486(76)80008-8","DOIUrl":"https://doi.org/10.1016/S0362-5486(76)80008-8","url":null,"abstract":"","PeriodicalId":101017,"journal":{"name":"Pharmacology & Therapeutics. Part C: Clinical Pharmacology and Therapeutics","volume":"1 1","pages":"101-118"},"PeriodicalIF":0.0,"publicationDate":"1976-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76571849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}